Início › Leucemia Linfoblástica Aguda › Califórnia › Los Angeles
Ensaios clínicos de Leucemia Linfoblástica Aguda em Los Angeles, CA
14 estudos para Leucemia Linfoblástica Aguda estão buscando participantes em locais em Los Angeles e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Recrutando
- Children's Hospital of Los Angeles, Los Angeles
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RecrutandoFase 2
- Children's Hospital Los Angeles, Los Angeles
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecrutandoFase 1/2
- Children's Hospital Los Angeles, Los Angeles
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RecrutandoFase 2
- Children's Hospital Los Angeles, Los Angeles
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
RecrutandoEstudo observacional
- University of California Los Angeles, Los Angeles
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
RecrutandoFase 1
- Cedars-Sinai Medical Center, Los Angeles
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecrutandoEstudo observacional
- UCLA, Los Angeles
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
RecrutandoFase 1/2
- Children's Hospital Los Angeles, Los Angeles
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
RecrutandoEstudo observacional
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
RecrutandoFase 3
- Ascentage Investigative Site #1134, Los Angeles
- Ascentage Investigative Site #1059, Los Angeles
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
RecrutandoFase 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Bright Ideas - CIN Feasibility Study
Recrutando
- Children's Hospital Los Angeles, Los Angeles
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
Recrutando
- Jackie and Gene Autry Orthopedic Center, CHLA, Los Angeles
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecrutandoFase 1
- Children's Hospital Los Angeles, Los Angeles
Ensaios de Leucemia Linfoblástica Aguda em outras cidades
- Houston, TX28 estudos
- New York City, NY23 estudos
- Seattle, WA21 estudos
- Baldwin Park, CA21 estudos
- Chicago, IL20 estudos
- Atlanta, GA19 estudos
- Memphis, TN16 estudos
- Washington, DC16 estudos
- Philadelphia, PA16 estudos
- Boston, MA15 estudos
- Mountain View, CA13 estudos
- Durham, NC13 estudos
Outros estudos em Los Angeles
- Câncer de Pulmão de Não Pequenas Células87 estudos
- Câncer (todos os tipos)74 estudos
- Câncer de Mama73 estudos
- Câncer de Próstata61 estudos
- Câncer Colorretal59 estudos
- Câncer Metastático57 estudos
- Câncer de Ovário50 estudos
- Câncer de Pulmão45 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço42 estudos
- Câncer de Pâncreas35 estudos
- Câncer Endometrial34 estudos
- Melanoma34 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.